A web-based artificial intelligence system for label-free virus classification and detection of cytopathic effects.

Publication date: Feb 18, 2025

Identifying viral replication within cells demands labor-intensive isolation methods, requiring specialized personnel and additional confirmatory tests. To facilitate this process, we developed an AI-powered automated system called AI Recognition of Viral CPE (AIRVIC), specifically designed to detect and classify label-free cytopathic effects (CPEs) induced by SARS-CoV-2, BAdV-1, BPIV3, BoAHV-1, and two strains of BoGHV-4 in Vero and MDBK cell lines. AIRVIC utilizes convolutional neural networks, with ResNet50 as the primary architecture, trained on 40,369 microscopy images at various magnifications. AIRVIC demonstrated strong CPE detection, achieving 100% accuracy for the BoGHV-4 DN-599 strain in MDBK cells, the highest among tested strains. In contrast, the BoGHV-4 MOVAR 33/63 strain in Vero cells showed a lower accuracy of 87. 99%, the lowest among all models tested. For virus classification, a multi-class accuracy of 87. 61% was achieved for bovine viruses in MDBK cells; however, it dropped to 63. 44% when the virus was identified without specifying the cell line. To the best of our knowledge, this is the first research article published in English to utilize AI for distinguishing animal virus infections in cell culture. AIRVIC’s hierarchical structure highlights its adaptability to virological diagnostics, providing unbiased infectivity scoring and facilitating viral isolation and antiviral efficacy testing. Additionally, AIRVIC is accessible as a web-based platform, allowing global researchers to leverage its capabilities in viral diagnostics and beyond.

Open Access PDF

Concepts Keywords
Antiviral BAdV-1
Microscopy BoAHV-1
Resnet50 BoGHV-4
Viral BPIV3
CPE
Deep learning
One health
SARS-COV-2

Semantics

Type Source Name
pathway KEGG Viral replication
disease IDO process
disease IDO cell
disease MESH virus infections
disease IDO infectivity
disease IDO host
disease IDO production
disease MESH influenza
disease MESH herpes simplex
drug DRUGBANK Coenzyme M
disease MESH polio
disease MESH parainfluenza
disease MESH vaccinia
disease IDO immunodeficiency
disease MESH COVID 19
disease IDO susceptibility
disease IDO replication
disease MESH shipping fever
disease MESH pneumonia
disease MESH infections
disease IDO bacteria
disease MESH enteritis
disease IDO infection
drug DRUGBANK Isoxaflutole
drug DRUGBANK Spinosad
disease IDO assay
disease MESH defects
disease MESH viral load
disease IDO facility
drug DRUGBANK Streptomycin
disease IDO reagent
drug DRUGBANK Water
drug DRUGBANK Phenol
drug DRUGBANK Isoamyl alcohol
drug DRUGBANK Flunarizine
drug DRUGBANK Etoperidone
disease IDO history
drug DRUGBANK Bismuth subgallate
disease MESH drug toxicity
disease MESH tumor
pathway REACTOME Budding
disease MESH colorectal carcinoma
disease MESH visna
disease MESH maedi
drug DRUGBANK Steviolbioside
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)